Pathogenic mechanisms in simian immunodeficiency virus infection

Current Opinion in HIV and AIDS

Volumn 3, Issue 3, 2008, Pages 380-386

  Grossman, Zvi ^a,b   Picker, Louis J ^c  

^a TEL AVIV UNIVERSITY   (Israel)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Chronic immune activation; Simian immunodeficiency virus pathogenesis; T cell dynamics

Indexed keywords

ANTIRETROVIRUS AGENT; CHEMOKINE RECEPTOR CCR5; CYCLOSPORIN A; INTERLEUKIN 15; INTERLEUKIN 7;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CD4+ T LYMPHOCYTE; CELL DEATH; CELL POPULATION; DISEASE COURSE; DRUG EFFICACY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOCOMPETENCE; LYMPHOCYTE DEPLETION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE MIGRATION; LYMPHOCYTE PROLIFERATION; MACACA; MEMORY T LYMPHOCYTE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS INFECTION; VIRUS REPLICATION;

EID: 42049120721     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0b013e3282fbaae6     Document Type: Review

References (57)

1. Hirsch VM, Lifson JD. Simian immunodeficiency virus infection of monkeys as a model system for the study of AIDS pathogenesis, treatment, and prevention. Adv Pharmacol 2000; 49:437-477.
2. Douek DC, Picker LJ, Koup RA. T cell dynamics in HIV-1 infection. Annu Rev Immunol 2003; 21:265-304.
3. Grossman Z, Meier-Schellersheim M, Paul WE, Picker LJ. Pathogenesis of HIV infection: what the virus spares is as important as what it destroys. Nat Med 2006; 12:289-295.
4. Haase AT. Perils at mucosal front lines for HIV and SIV and their hosts. Nat Rev Immunol 2005; 5:783-792.
5. Monceaux V, Viollet L, Petit F, et al. CD4+ CCR5+ T-cell dynamics during simian immunodeficiency virus infection of Chinese rhesus macaques. J Virol 2007; 81:13865-13875.
6. Letvin NL, King NW. Immunologic and pathologic manifestations of the infection of rhesus monkeys with simian immunodeficiency virus of macaques. J Acquir Immune Defic Syndr 1990; 3:1023-1040.
7. Gallo RC, Sarin PS, Gelmann EP, et al. Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS). Science 1983; 220:865-867.
8. Klatzmann D, Barre-Sinoussi F, Nugeyre MT, et al. Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes. Science 1984; 225:59-63.
9. Rodriguez B, Sethi AK, Cheruvu VK, et al. Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection. JAMA 2006; 296:1498-1506.
10. Giorgi JV, Hultin LE, McKeating JA, et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 1999; 179:859-870.
11. Deeks SG, Kitchen CM, Liu L, et al. Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood 2004; 104:942-947.
12. Hazenberg MD, Hamann D, Schuitemaker H, Miedema F. T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock. Nat Immunol 2000; 1:285-289.
13. Silvestri G, Paiardini M, Pandrea I, et al. Understanding the benign nature of SIV infection in natural hosts. J Clin Invest 2007; 117:3148-3154. This paper is an interesting commentary on the advances that have been made in understanding the mechanisms underlying the remarkable difference in infection outcome between natural and nonnatural HIV/SIV hosts.
14. Grossman Z, Herberman RB. T-cell homeostasis in HIV infection is neither failing nor blind: modified cell counts reflect an adaptive response of the host. Nat Med 1997; 3:486-490.
15. Grossman Z, Meier-Schellersheim M, Sousa AE, et al. CD4+ T-cell depletion in HIV infection: are we closer to understanding the cause? Nat Med 2002; 8:319-323.
16. Anderson RW, Ascher MS, Sheppard HW. Direct HIV cytopathicity cannot account for CD4 decline in AIDS in the presence of homeostasis: a worst-case dynamic analysis. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 17:245-252.
17. Mohri H, Perelson AS, Tung K, et al. Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy. J Exp Med 2001; 194:1277-1287.
18. Mohri H, Bonhoeffer S, Monard S, et al. Rapid turnover of T lymphocytes in SIV-infected rhesus macaques. Science 1998; 279:1223-1227.
19. Picker LJ, Hagen SI, Lum R, et al. Insufficient production and tissue delivery of CD4+ memory T cells in rapidly progressive simian immunodeficiency virus infection. J Exp Med 2004; 200:1299-1314.
20. EM populations in chronic progression and, therefore, determines the tempo of disease progression, 'setting the clock' with respect to the onset of overt AIDS.
21. Silvestri G, Feinberg MB. Turnover of lymphocytes and conceptual paradigms in HIV infection. J Clin Invest 2003; 112:821-824.
22. Hirsch VM. What can natural infection of african monkeys with simian immunodeficiency virus tell us about the pathogenesis of AIDS. AIDS ev 2004; 6:40-53.
23. CM from both direct and indirect destruction in nonpathogenic infections.
24. CM renewal and differentiation, was not present in nonpathogenic SIV infections of sooty mangabey, constituting another level of protection for these natural hosts.
25. Pereira LE, Villinger F, Onlamoon N, et al. Simian immunodeficiency virus (SIV) infection influences the level and function of regulatory T cells in SIV-infected rhesus macaques but not SIV-infected sooty mangabeys. J Virol 2007; 81:4445-4456.
26. + memory T cells than four species of nonadapted, AIDS-susceptible hosts suggests that this alteration may be a key adaptation acquired during the coevolution between the virus and its natural hosts that led to nonpathogenic infection.
27. + T cell function, or that immune activation must also present for the development of AIDS.
28. Sumpter B, Dunham R, Gordon S, et al. Correlates of preserved CD4(+) T cell homeostasis during natural, nonpathogenic simian immunodeficiency virus infection of sooty mangabeys: implications for AIDS pathogenesis. J Immunol 2007; 178:1680-1691.
29. Lederman MM, Smeaton L, Smith KY, et al. Cyclosporin A provides no sustained immunologic benefit to persons with chronic HIV-1 infection starting suppressive antiretroviral therapy: results of a randomized, controlled trial of the AIDS Clinical Trials Group A5138. J Infect Dis 2006; 194:1677-1685.
30. + T cell response.
31. Lackner AA, Veazey RS. Current concepts in AIDS pathogenesis: insights from the SIV/macaque model. Annu Rev Med 2007; 58:461-476.
32. Cheroutre H, Madakamutil L. Acquired and natural memory T cells join forces at the mucosal front line. Nat Rev Immunol 2004; 4:290-300.
33. Mowat AM, Viney JL. The anatomical basis of intestinal immunity. Immunol Rev 1997; 156:145-166.
34. Ganusov VV, De Boer RJ. Do most lymphocytes in humans really reside in the gut? Trends Immunol 2007; 28:514-518. Reviewing data from different mammalian species, the authors concluded that only 5-20% of all lymphocytes reside in the gut, and that only 1-9% of the total lymphocyte number is located in the gut lamina propria.
35. Centlivre M, Sala M, Wain-Hobson S, Berkhout B. In HIV-1 pathogenesis the die is cast during primary infection. AIDS 2007; 21:1-11.
36. Gordon SN, Klatt NR, Bosinger SE, et al. Severe depletion of mucosal CD4+ T cells in AIDS-free simian immunodeficiency virus-infected sooty mangabeys. J Immunol 2007; 179:3026-3034. Surprisingly, the nonpathogenic SIV infection of sooty mangabeys was found to induce the same pattern of mucosal target cell depletion observed during pathogenic HIV/SIV infections. The depletion in sooty mangabeys occurs, however, in the context of limited local and systemic immune activation and can be reverted if virus replication is suppressed by antiretroviral therapy.
37. + memory T cells in mucosal effector sites is also seen in apathogenic SIV infections of African green monkeys. Significantly, this report further demonstrates that in the absence of immune activation, this depletion is nonprogressive, and is often partially restored.
38. Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006; 12:1365-1371. This provocative study identified a striking association between immune activation in pathogenic HIV/SIV infection and circulating microbial products, likely derived from the gastrointestinal tract and indicative of mucosal translocation through damaged gut epithelium. The relative contribution of such microbial translocation vs. other innate immune stimuli to the pathologic immune activation of progressive HIV/SIV infection remains to be determined, as well as the potential relationship between absence of translocation and the normalization of immune activation following the onset of nonpathogenic SIV infections of natural hosts.
39. Lempicki RA, Kovacs JA, Baseler MW, et al. Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T cell turnover in HIV-infected patients. Proc Natl Acad Sci U S A 2000; 97:13778-13783.
40. Appay V, Almeida JR, Sauce D, et al. Accelerated immune senescence and HIV-1 infection. Exp Gerontol 2007; 42:432-437.
41. Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 2004; 22:745-763.
42. Lanzavecchia A, Sallusto F. Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. Science 2000; 290:92-97.
43. EM in vivo, and is likely a primary regulator of the dynamics of these populations in progressive HIV/SIV infection.
44. Hellerstein MK, Hoh RA, Hanley MB, et al. Subpopulations of long-lived and short-lived T cells in advanced HIV-1 infection. J Clin Invest 2003; 112:956-966.
45. Nishimura Y, Igarashi T, Buckler-White A, et al. Loss of naive cells accompanies memory CD4+ T-cell depletion during long-term progression to AIDS in Simian immunodeficiency virus-infected macaques. J Virol 2007; 81:893-902.
46. Arron ST, Ribeiro RM, Gettie A, et al. Impact of thymectomy on the peripheral T cell pool in rhesus macaques before and after infection with simian immunodeficiency virus. Eur J Immunol 2005; 35:46-55.
47. Grossman Z, Min B, Meier-Schellersheim M, Paul WE. Concomitant regulation of T-cell activation and homeostasis. Nat Rev Immunol 2004; 4:387-395.
48. Akbar AN, Vukmanovic-Stejic M. Telomerase in T lymphocytes: use it and lose it? J Immunol 2007; 178:6689-6694.
49. Schacker TW, Reilly C, Beilman GJ, et al. Amount of lymphatic tissue fibrosis in HIV infection predicts magnitude of HAART-associated change in peripheral CD4 cell count. AIDS 2005; 19:2169-2171.
50. Moniuszko M, Fry T, Tsai WP, et al. Recombinant interleukin-7 induces proliferation of naive macaque CD4+ and CD8+ T cells in vivo. J Virol 2004; 78:9740-9749.
51. Fry TJ, Moniuszko M, Creekmore S, et al. IL-7 therapy dramatically alters peripheral T-cell homeostasis in normal and SIV-infected nonhuman primates. Blood 2003; 101:2294-2299.
52. Alves NL, Hooibrink B, Arosa FA, van Lier RA. IL-15 induces antigenin-dependent expansion and differentiation of human naive CD8+ T cells in vitro. Blood 2003; 102:2541-2546.
53. Muthukumar A, Wozniakowski A, Gauduin MC, et al. Elevated interleukin-7 levels not sufficient to maintain T-cell homeostasis during simian immunodeficiency virus-induced disease progression. Blood 2004; 103:973-979.
54. Biancotto A, Grivel JC, Iglehart SJ, et al. Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1. Blood 2007; 109:4272-4279.
55. Yoshimura A, Naka T, Kubo M. SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol 2007; 7:454-465.
56. EM.
57. CM in HIV-positive subjects.